Interview

Dogs or mice? Our exclusive with Dr Steven Austad

Biotech Clinical trials Drugs

The Longevity biotech industry is hitting its stride

Economy Innovation Investment Investment Tissue/Organ

Aging not playing-out as expected: It’s better

Investment Investment

XenoTherapeutics gears up for Series A in 2020

Innovation Tissue/Organ Xenotransplantation

Brexit an opportunity for Longevity sector

Investment Investment

Nuritas reveals new Longevity peptides

Agetech Supplements Wellness

Forever Young – our exclusive with Sergey Young

Investment

Exclusive Profile: The Buck Institute’s Eric Verdin

Agetech

“All of this happening … is really a major inflection point”

Investment Investment